| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.108.807917 |
| P698 | PubMed publication ID | 18852376 |
| P2093 | author name string | Akshay Desai | |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1609-1611 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit | |
| P478 | volume | 118 |
| Q35158709 | Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs |
| Q37641425 | Hyperkalemia in patients with heart failure: incidence, prevalence, and management |
| Q36008616 | Impact of hyperkalaemia definition on incidence assessment: implications for epidemiological research based on a large cohort study in newly diagnosed heart failure patients in primary care |
| Q34372881 | Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial |
| Q57814734 | Kidney Function, ACE-Inhibitor/Angiotensin Receptor Blocker Use, and Survival Following Hospitalization for Heart Failure: A Cohort Study |
| Q38391211 | Managing chronic diseases in the frail elderly: More than just adhering to clinical guidelines |
| Q46757983 | Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study |
| Q37347190 | New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option? |
| Q38960882 | Noninvasive quantification of blood potassium concentration from ECG in hemodialysis patients |
| Q34455761 | Oral sodium and potassium binders in heart failure |
| Q38416821 | Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case-control study in UK general practice |
| Q30893153 | Risk of hyperkalemia and combined use of spironolactone and long-term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real-life data: a population- and insurance-based cohort |
| Q37902667 | What is the risk of hyperkalaemia in heart failure? |
Search more.